Evaluate the Diagnostic Efficacy and Safety of INR 202 PET/CT Imaging in Participants With Advanced Solid Tumors

Sponsor
Shanghai Zhongshan Hospital
Study ID
NCT07727317
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Solid Tumors

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • INR202+FDG — DIAGNOSTIC_TEST
    single administration

Study Details

This is a prospective, single-center, open-label clinical study comparing the imaging performance of INR202 PET/CT versus 18F-FDG PET/CT in participants with advanced solid tumors.

Key Dates

First listed
Jul 27, 2026
Start date
Aug 31, 2026
Status verified
Jul 2026
Primary completion
Jul 31, 2028
Completion
Jul 31, 2028

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: INR202+FDG
    All eligible participants will receive a single administration of INR202 injection. A PET/CT scan will be performed post-dose. All subjects will undergo a follow-up visit during the safety follow-up period. Subsequently, subjects will undergo 18F-FDG PET/CT imaging.

Primary Outcome Measure

Number of detected lesions [ Time Frame: From Day 1 to Day 10 ]

Related Studies